Cytologic evaluation of lumpectomy margins in patients with ductal carcinoma in situ: Clinical outcome

Annals of Surgical Oncology

Volumn 4, Issue 8, 1997, Pages 644-649

  Cox, Charles E ^a   Hyacinthe, Micheline ^a   Gonzalez, Ricardo J ^a   Lyman, Gary ^a   Reintgen, Douglas ^a   Ku, Ni Ni ^a   Miller, Marcia S ^a   Greenberg, Harvey ^a   Nicosia, Santo V ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

DCIS; Lumpectomy margin determination; Recurrence; Touch preparation cytology

Indexed keywords

ADULT; AGED; ARTICLE; BREAST TUMOR; CARCINOMA IN SITU; CYTODIAGNOSIS; FEMALE; HUMAN; METHODOLOGY; MIDDLE AGED; PAGET NIPPLE DISEASE; PEROPERATIVE CARE; PROSPECTIVE STUDY; REPRODUCIBILITY; SEGMENTAL MASTECTOMY; SENSITIVITY AND SPECIFICITY; SURVIVAL; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CYTODIAGNOSIS; FEMALE; HUMANS; INTRAOPERATIVE CARE; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 0031298893     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303749     Document Type: Review

References (25)

1. Rosner D, Bedwani RN, Vana J, Baker HW, Murphy GP. Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons. Ann Surg 1980;192:139-47.
2. Baker LH. Breast Cancer Detection Demonstration Project: five year summary report. CA Cancer J Clin 1982;32:194-225.
3. Peters PHM, Verbeck ALM, Straatman H, Holland R, Hendricks JH, Mravunac M, Rothergatter C. Evaluation of overdiagnosis of breast cancer in screening with mammography. Int J Epidemiol 1989;18:295-9.
4. Schwartz GF, Patchefsky AS, Feig SA, Shaber GS, Schwartz AB. Clinically occult breast cancer: multicentricity and implications for treatment. Ann Surg 1980;191:8-12.
5. Rosen PP. Lobular carcinoma in-situ and intraductal carcinoma of the breast. Monogr Pathol 1984;25:59-105.
6. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Ductal carcinoma in situ: relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastasis, and short term treatment failures. Cancer 1982;50:1309-14.
7. Kinne DW, Petrek JA, Osborne MP, Fracchia AA, De Palo AA, Rosen PP. Breast carcinoma in-situ. Arch Surg 1989;124:33-6.
8. Silverstein MJ, Waisman JR, Gierson ED, Colbum W, Gamagami P, Lewinski BS. Radiation therapy for intraductal carcinoma: is it an equal alterative? Ann Surg 1991;126:424-8.
9. Hetelekidis S, Scnitt SJ, Morrow M, Harris JR. Management of ductal carcinoma in-situ. CA Cancer J Clin 1995;45:244-53.
10. Frazier TG, Wong RW, Rose D. Implications of accurate pathologic margins in the treatment of primary breast cancer. Arch Surg 1989;124:37-8.
11. Schnitt SJ, Connolly JL, Harris JR, Hellman S, Cohen RB. Pathologic predictors of early local recurrence in stage I and stage II breast cancer treated by radiation therapy. Cancer 1984;53:1049-57.
12. Recht A, Silver B, Schnitt SJ, Connolly J, Hellman S, Harris JR. Breast relapse following primary radiation therapy for early breast cancer: I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys 1985;11:1271-6.
13. Holland R, Hendricks JH, Verbeck ALM, Mravunac M, Stekhov JH. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990;335:519-22.
14. Cox CE, Ku NN, Reintgen D, Greenburg HM, Nicosia SV, Wangensteen S. Touch preparation cytology of breast lumpectomy margins with histologic correlation. Arch Surg 1991;126:490-3.
15. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C. Incidence and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275:913-8.
16. Bartelink H, Bolder JH, Vandongen JA, Peterse JL. The impact of tumor size and histology on local control after breast conservation therapy. Radiother Oncol 1988;11:297-303.
17. Veronesi U, Banfi A, Del Vecchio M, et al. Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long term results. Eur J Cancer Clin Oncol 1986;22:1085-9.
18. Silverstein M, Cohlan B, Gierson E, Furmanski M, Gamagami P, Colburn W, Lewinski B. Ductal carcinoma in situ: 227 cases without microinvasion. Eur J Cancer 1992;28:630-4.
19. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996;274:2057-9.
20. Lagios M, Margolin F, Westdahl P, Rose M. Mammographically detected ductal carcinoma in-situ. Cancer 1989;63:618-24.
21. Fisher E, Sass R, Fisher B, Wickerham L, Paik S. Pathologic findings from the NSABP-6 (DCIS). Cancer 1986;57:197-208.
22. Hardman PDJ, Worth A, Lee D, Baird RM. The risk of occult invasive breast cancer after excisional biopsy showing in situ ductal carcinoma of comedo pattern. Can J Surg 1989;32:56-60.
23. Wobbes T, Tinnemans JGM, van der Sluis RF. Residual tumor after biopsy for non-palpable ductal carcinoma in situ of the breast. Br J Surg 1989;76:185-6.
24. Schwartz GF, Finkel G, Garcia J, Patchefsky A. Subclinical Ductal Carcinoma In Situ of the Breast. Cancer 1992;70:2468-2474.
25. Klinberg VS, Westbrook KC, Korourian SR. Use of touch preps for diagnosis in surgical margins in breast cancer. Proceedings from Annual Cancer Symposia, Society of Surgical Oncology. March 1996, Altanta, GA.